ERBB2 and neoplasm: (36) reported a higher risk for HER2-positive subtypes in Latinas, either for the luminal/HER2 (odd ratio (OR)=1.1, 95% confidence interval (CI), 1.0–1.2) or the HER2-enriched subtype (OR=1.4, 95% CI, 1.2–1.6), compared to NHWs, in a model adjusted by age, stage, tumor grade, and SEER registry.